Microrna-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis

Hepato-Gastroenterology

Volumn 61, Issue 133, 2014, Pages 1302-1307

  Li, Yunqiao ^a   Hu, Yanke ^b   Xue, Jun ^a   Guo, Tangmeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Hepatocellular carcinoma; Invasion; MicroRNA 206; Migration; Proliferation

Indexed keywords

MICRORNA; MICRORNA 206; OLIGONUCLEOTIDE; SCLEROPROTEIN; UNCLASSIFIED DRUG; MIRN206 MICRORNA, HUMAN;

ADULT; APOPTOSIS; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURGERY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PATHOGENESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; TUMOR DIFFERENTIATION; TUMOR VOLUME; CELL DIFFERENTIATION; CELL MOTION; GENETIC TRANSFECTION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; SECONDARY; TUMOR INVASION;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; TRANSFECTION;

EID: 84906974464     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge14175     Document Type: Article

References (32)

1. Blum HE, Spangenberg HC: Hepatocellular carcinoma: an update. Arch Iran Med 2007:10(3): 361-371. (Pubitemid 47162535)
2. Osman A: MicroRNAs in health and disease - basic science and clinical applications. Clin Lab 2012:58(5-6): 393-402.
3. Zhao G, Cai C, Yang T, et al: MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma. PLoS One 2013;8(1): e53906.
4. Mendell JT, Olson EN: MicroRNAs in stress signaling and human disease. Cell 2012:148(6): 1172-1187.
5. Dieckmann KP, Spiekermann M, Balks T, et al: MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 2012:107(10): 1754-1760.
6. Takahashi M, Cuatrecasas M, Balaguer F, et al: The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer. PLoS One 2012:7(10): e46684.
7. Wei R, Huang GL, Zhang MY, et al: Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma. Clin Cancer Res 2013:19(17): 4780-4791.
8. Guo J, Friedman SL: The expression patterns and clinical significance of microRNAs in liver diseases and hepatocellular carcinoma. Curr Pharm Des 2013;19(7): 1262-1272.
9. He XX, Chang Y, Meng FY, et al: MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012:31(28): 3357-3369.
10. Rong M, He R, Dang Y, et al: Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues. Ups J Med Sci 2013.
11. Zhang J, Yang Y, Yang T, et al: microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 2010;103(8): 1215-1220.
12. Chen P, Zhao X, Ma L: Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma. Mol Cell Biochem 2013:383(1-2): 49-58.
13. Rao PK, Kumar RM, Farkhondeh M, et al: Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A 2006:103(23): 8721-8726. (Pubitemid 43878086)
14. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005:65(16): 7065-7070. (Pubitemid 41161233)
15. Wang X, Ling C, Bai Y, et al: MicroRNA-206 is associated with invasion and metastasis of lung cancer. Anat Rec (Hoboken) 2011;294(1): 88-92.
16. Zhang L, Liu X, Jin H, et al: miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2. Cancer Lett 2013;332(1): 94-101.
17. Parasramka MA, Dashwood WM, Wang R, et al: A role for low-abundance miRNAs in colon cancer: the miR-206/Kruppel-like factor 4 (KLF4) axis. Clin Epigenetics 2012:4(1): 16.
18. Zhang T, Liu M, Wang C, et al: Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression. Anticancer Res 2011:31(11): 3859-3863.
19. Zhou L, Chen J, Li Z, et al: Integrated profiling of microRNAs and mRNAs: microRNAs located on Xq27.3 associate with clear cell renal cell carcinoma. PLoS One 2010:5(12): e15224.
20. Chen X, Yan Q, Li S, et al: Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERalpha-positive endometrioid adenocarcinoma. Cancer Lett 2012:314(1): 41-53.
21. Wang R, Hu Y, Song G, et al: MiR-206 regulates neural cells proliferation and apoptosis via Otx2. Cell Physiol Biochem 2012:29(3-4): 381-390.
22. Missiaglia E, Shepherd CJ, Patel S, et al: MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br J Cancer 2010;102(12): 1769-1777.
23. Bao YP, Yi Y, Peng LL, et al: Roles of microRNA-206 in osteosarcoma pathogenesis and progression. Asian Pac J Cancer Prev 2013:14(6): 3751-3755.
24. Yang Q, Zhang C, Huang B, et al: Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer. Eur J Gastroenterol Hepatol 2013:25(8): 953-957.
25. Vickers MM, Bar J, Gorn-Hondermann I, et al: Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease. Clin Exp Metastasis 2012:29(2): 123-132.
26. Leivonen SK, Makela R, Ostling P, et al: Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 2009:28(44): 3926-3936.
27. Taulli R, Bersani F, Foglizzo V, et al: The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 2009;119(8): 2366-2378.
28. Dey BK, Gagan J, Dutta A: miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol 2011:31(1): 203-214.
29. Song G, Zhang Y, Wang L: MicroRNA-206 targets notch3, activates apoptosis, and inhibits tumor cell migration and focus formation. J Biol Chem 2009;284(46): 31921-31927.
30. Kondo N, Toyama T, Sugiura H, et al: miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res 2008:68(13): 5004-5008.
31. Brennecke J, Stark A, Russell RB, et al: Principles of microRNA-target recognition. PLoS Biol 2005:3(3): e85.
32. Krek A, Grun D, Poy MN, et al: Combinatorial microRNA target predictions. Nat Genet 2005:37(5): 495-500. (Pubitemid 40617277)